94 related articles for article (PubMed ID: 12599418)
1. [Inhibitory effect of cationic liposome-mediated antisense c-myb oligonucleotide on the growth of glioma].
Zhao D; You C; Huang G; Liao X; Tan H
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):19-22. PubMed ID: 12599418
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of antisense c-myb cDNA on the growth of asynchronous glioma cells in vivo].
Xu X; You C; Huang S; Zhang S; Yi Z
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):562-5. PubMed ID: 12528549
[TBL] [Abstract][Full Text] [Related]
3. [Expression and implication of c-myb and bcl-2 proteins in C6 gliomas].
You C; Xu X; Cal B; Zhang S
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):304-5, 318. PubMed ID: 12545815
[TBL] [Abstract][Full Text] [Related]
4. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of antisense epidermal growth factor receptor RNA on the proliferation of rat C6 glioma cells in vitro and in vivo.
Pu P; Liu X; Liu A; Cui J; Zhang Y
J Neurosurg; 2000 Jan; 92(1):132-9. PubMed ID: 10616092
[TBL] [Abstract][Full Text] [Related]
6. The activity of c-myb antisense oligonucleotide to prevent intimal hyperplasia is nonspecific.
Castier Y; Chemla E; Nierat J; Heudes D; Vasseur MA; Rajnoch C; Bruneval P; Carpentier A; Fabiani JN
J Cardiovasc Surg (Torino); 1998 Feb; 39(1):1-7. PubMed ID: 9537527
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
8. [Effects of an anti-c-myb antisense oligonucleotide on myo-intimal proliferation. Specificity of action and consequences on vasoreactivity].
Castier Y; Chemla E; Chardigny C; Nierat J; Eudes D; Vasseur MA; Bruneval P; Carpentier A; Fabiani JN
Arch Mal Coeur Vaiss; 1996 Jul; 89(7):889-96. PubMed ID: 8869251
[TBL] [Abstract][Full Text] [Related]
9. Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin.
Funato T; Satou J; Kozawa K; Fujimaki S; Miura T; Kaku M
Oncol Rep; 2001; 8(4):807-10. PubMed ID: 11410788
[TBL] [Abstract][Full Text] [Related]
10. A DNA uptake-stimulating protein increases the antiproliferative effect of c-myb antisense oligonucleotide on leukemic cells.
Tóth G; Schlammadinger J; Aradi J; Antal-Szalmás P; Sipka S; Balázs M; Kovács P; Fehér Z; Falus A
Cell Biol Int; 2004; 28(11):817-23. PubMed ID: 15563404
[TBL] [Abstract][Full Text] [Related]
11. [Effects of lipofectin-mediated alpha1,4Gal T antisense oligonucleotide on human glioma cell line SWO-38].
Zheng G; Zhang JR; Liu FQ; Rao ZG; Wang XW; Zhang XY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):299-302. PubMed ID: 12390727
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
Saleh M; Stacker SA; Wilks AF
Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
[TBL] [Abstract][Full Text] [Related]
13. [Effects of antisense oligonuclotide on c-myb expression in rats with liver fibrosis].
Ma HH; Yao JL; Yao CL; Li G; Chen XJ; Lu JX; Yang SJ
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):309, 311. PubMed ID: 12773251
[No Abstract] [Full Text] [Related]
14. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of c-sis protein synthesis and cell growth with antisense oligonucleotides in human glioma cells].
Nitta T; Sato K
No Shinkei Geka; 1992 Aug; 20(8):857-63. PubMed ID: 1508312
[TBL] [Abstract][Full Text] [Related]
16. The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo.
Pu P; Kang C; Li J; Jiang H; Cheng J
J Neurooncol; 2006 Jan; 76(1):1-11. PubMed ID: 16402276
[TBL] [Abstract][Full Text] [Related]
17. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.
Pagnan G; Stuart DD; Pastorino F; Raffaghello L; Montaldo PG; Allen TM; Calabretta B; Ponzoni M
J Natl Cancer Inst; 2000 Feb; 92(3):253-61. PubMed ID: 10655443
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of c-sis protein synthesis and cell proliferation with antisense oligodeoxynucleotides in human glioma cells.
Nitta T; Sato K
Neurosurgery; 1994 Feb; 34(2):309-14; discussion 314-5. PubMed ID: 8177392
[TBL] [Abstract][Full Text] [Related]
19. [Vascular endothelial growth factor shRNA mediated by pEGFP-H1 vector plasmid effectively inhibits glioma proliferation: an experimental study].
Jiang XB; Zhao HY; Zhou F; Liu RE; Zhang FC; Zhao JS
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):547-50. PubMed ID: 15949336
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.
Brignole C; Pagnan G; Marimpietri D; Cosimo E; Allen TM; Ponzoni M; Pastorino F
Cancer Lett; 2003 Jul; 197(1-2):231-5. PubMed ID: 12880987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
